These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10307448)

  • 1. The cost of government constraints.
    Best J
    Drug Inf J; 1977; 11(4):203-4. PubMed ID: 10307448
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs associated with drug information.
    Bachynsky JA
    Drug Inf J; 1977; 11(4):193-4. PubMed ID: 10307445
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost present--cost future.
    Thomson A
    Drug Inf J; 1977; 11(4):197-202. PubMed ID: 10307447
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach to providing consumer information at low incremental cost.
    Tattle PT
    Drug Inf J; 1977; 11(4):195-6. PubMed ID: 10307446
    [No Abstract]   [Full Text] [Related]  

  • 5. Who will bear the cost for drug information to the consumer: costs vs benefits of various sources.
    Fraser RD
    Drug Inf J; 1977; 11(4):190-2. PubMed ID: 10307444
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug information risks under the Freedom of Information Act.
    Cuddihy RV
    Drug Inf J; 1978; 12(1):40-4. PubMed ID: 10308104
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative description of common secondary drug information systems.
    Watanabe AS; Groth PE
    Drug Inf J; 1979; 13(1):31-4. PubMed ID: 10242950
    [No Abstract]   [Full Text] [Related]  

  • 8. A drug problem reporting system for Canadian hospital pharmacies.
    Friedel H; Gibson C
    Can J Hosp Pharm; 1978; 31(6):205-6. PubMed ID: 10240006
    [No Abstract]   [Full Text] [Related]  

  • 9. [The public health portal for physicians--a double cost for the state?].
    Thirup P; Lange B
    Ugeskr Laeger; 2003 Sep; 165(36):3438-9. PubMed ID: 14531153
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed government role in drug information.
    Spino M
    Drug Inf J; 1978; 12(1):26-8. PubMed ID: 10308101
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug information in perspective.
    Everson RE
    Drug Inf J; 1977; 11(3):146-52. PubMed ID: 10307436
    [No Abstract]   [Full Text] [Related]  

  • 12. Government as coordinator of drug information.
    Philbrook F
    Drug Inf J; 1978; 12(1):37-9. PubMed ID: 10316627
    [No Abstract]   [Full Text] [Related]  

  • 13. How to ask drug companies for help.
    Hayes JD
    Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug information and pharmaceutical quality control.
    Stroud RR
    Drug Inf J; 1978; 12(1):20-2. PubMed ID: 10308100
    [No Abstract]   [Full Text] [Related]  

  • 15. A preliminary research note: on-line information systems: their potential value to the practicing physician.
    Cuddihy RV
    Drug Inf J; 1975; 9(1):7-9. PubMed ID: 10297121
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug information utilization--the need for government/industry communications.
    Gelberg A
    Drug Inf J; 1978; 12(3):163-6. PubMed ID: 10239113
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug information: the pharmaceutical manufacturer's viewpoint and involvement.
    Meadows RJ
    Drug Inf J; 1977; 11(4):221-4. PubMed ID: 10307453
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmaceutical manufacturers representative.
    Roustan PT
    Drug Inf J; 1978; 12(1):15-9. PubMed ID: 10308099
    [No Abstract]   [Full Text] [Related]  

  • 19. The function of drug company representatives.
    Hemminki E; Pesonen T
    Scand J Soc Med; 1977; 5(3):105-14. PubMed ID: 594704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to pesticide registration data in Canada: who should know?
    Cohen FG; White FM; McCurdy RF; Côté RP
    CMAJ; 1987 Feb; 136(4):329-32. PubMed ID: 3815193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.